ENOCH J. SAPHIRE, M.D.
This content is PDF only. Please click on the PDF icon to access.
The focus of attention in the treatment of hypertensive disease has turned toward the use of hypotensive drugs. Among a number of hypotensive drugs which have stimulated interest are preparations of Veratrum viride and its derivatives. V. viride is not new to pharmacologic or clinical experience. A rebirth of interest in this drug followed more accurate standardization and better knowledge of its composition and actions.4, 10, 5
An oral preparation of Veriloid is evaluated in this study. Veriloid is a standardized mixture of hypotensive alkaloids of V. viride20 whose main pharmacologic actions produce hypotension, bradycardia and emesis. The chemical structure
SAPHIRE EJ. A CLINICAL EVALUATION OF ORAL VERILOID IN THE TREATMENT OF HYPERTENSIVE DISEASE*. Ann Intern Med. 1954;41:1211–1224. doi: https://doi.org/10.7326/0003-4819-41-6-1211
Download citation file:
Published: Ann Intern Med. 1954;41(6):1211-1224.
Cardiology, Coronary Risk Factors, Hypertension, Nephrology.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use